Search research articles
Contact Us
Filters
Showing results (101-110 of 186) with videos related to
Page
of 19
Sort By:
Cancer Research
|
August 6, 2009
Small-molecule multidrug resistance-associated protein 1 inhibitor reversan increases the therapeutic index of chemotherapy in mouse models of neuroblastoma
Catherine A Burkhart, Fujiko Watt, Jayne Murray, et al.
Journal of Proteomics
|
November 9, 2013
Identification of plasma complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach
Patrick Y Kim, Owen Tan, Sonya M Diakiw, et al.
British Journal of Cancer
|
April 10, 2021
Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofin
Mawar Karsa, Angelika Kosciolek, Angelika Bongers, et al.
Pediatrics
|
August 7, 2025
Immune Response to COVID-19 Vaccination in Children With Cancer
Amy Body, Luxi Lal, Peter Downie, et al.
Nature Communications
|
February 13, 2021
Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomas
Aaminah Khan, Laura D Gamble, Dannielle H Upton, et al.
Cancer Research
|
April 4, 2018
Network Modeling of microRNA-mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCN
Chi Yan Ooi, Daniel R Carter, Bing Liu, et al.
British Journal of Cancer
|
January 11, 2020
Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy
Alvin Kamili, Andrew J Gifford, Nancy Li, et al.
Cancer Medicine
|
November 6, 2024
Combined inhibition of histone methyltransferases EZH2 and DOT1L is an effective therapy for neuroblastoma
Janith A Seneviratne, Daenikka Ravindrarajah, Daniel R Carter, et al.
Cancer Research
|
August 21, 2020
Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion
Florida Voli, Emanuele Valli, Luigi Lerra, et al.
Cancer Research Communications
|
July 10, 2025
Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
Nadine Azzam, Jamie I Fletcher, Nicole Melong, et al.
Page
of 19
Search research articles
Search
Showing results (101-110 of 186) with videos related to
Sort By:
Page
of 19
Cancer Research
|
August 6, 2009
Small-molecule multidrug resistance-associated protein 1 inhibitor reversan increases the therapeutic index of chemotherapy in mouse models of neuroblastoma
Catherine A Burkhart, Fujiko Watt, Jayne Murray, et al.
Journal of Proteomics
|
November 9, 2013
Identification of plasma complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach
Patrick Y Kim, Owen Tan, Sonya M Diakiw, et al.
British Journal of Cancer
|
April 10, 2021
Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofin
Mawar Karsa, Angelika Kosciolek, Angelika Bongers, et al.
Pediatrics
|
August 7, 2025
Immune Response to COVID-19 Vaccination in Children With Cancer
Amy Body, Luxi Lal, Peter Downie, et al.
Nature Communications
|
February 13, 2021
Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomas
Aaminah Khan, Laura D Gamble, Dannielle H Upton, et al.
Cancer Research
|
April 4, 2018
Network Modeling of microRNA-mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCN
Chi Yan Ooi, Daniel R Carter, Bing Liu, et al.
British Journal of Cancer
|
January 11, 2020
Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy
Alvin Kamili, Andrew J Gifford, Nancy Li, et al.
Cancer Medicine
|
November 6, 2024
Combined inhibition of histone methyltransferases EZH2 and DOT1L is an effective therapy for neuroblastoma
Janith A Seneviratne, Daenikka Ravindrarajah, Daniel R Carter, et al.
Cancer Research
|
August 21, 2020
Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion
Florida Voli, Emanuele Valli, Luigi Lerra, et al.
Cancer Research Communications
|
July 10, 2025
Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
Nadine Azzam, Jamie I Fletcher, Nicole Melong, et al.
Page
of 19